SCHEMBL25970233

SCHEMBL25970233

NCCCNC(=O)c1cc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 2/20 0.69
PAOX Q6QHF9 2/20 0.69
ADRA2A P08913 1/20 0.69
ADRA2B P18089 1/20 0.69
HTR1D P28221 1/20 0.69
HTR1B P28222 1/20 0.69
HTR2B P41595 1/20 0.69
TMEM97 Q5BJF2 1/20 0.69
SMOX Q9NWM0 1/20 0.69
KDM4E B2RXH2 8/20 0.62
ALDH1A1 P00352 7/20 0.62
HTT P42858 2/20 0.62
CHRM4 P08173 1/20 0.60
DRD4 P21917 1/20 0.60
ADRA1B P35368 1/20 0.60
DRD3 P35462 1/20 0.60
SLC6A3 Q01959 1/20 0.60
TP53 P04637 6/20 0.59
MAPT P10636 4/20 0.59
HPGD P15428 6/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25970334 0.93 OPRK1 (0.66) OPRK1PAOXADRA2AADRA2BHTR1D
Hydrochloric Acid SCHEMBL30516229 0.92 OPRK1 (0.64) OPRK1PAOXADRA2AADRA2BHTR1D
SCHEMBL25970331 0.88 OPRK1 (0.68) OPRK1PAOXADRA2AADRA2BHTR1D
SCHEMBL25969026 0.87 OPRK1 (0.67) OPRK1PAOXADRA2AADRA2BHTR1D
SCHEMBL1719216 0.85 OPRK1 (0.64) OPRK1PAOXADRA2AADRA2BHTR1D
SCHEMBL25968911 0.84 OPRK1 (0.69) OPRK1PAOXADRA2AADRA2BHTR1D
SCHEMBL25969267 0.84 OPRK1 (0.69) OPRK1PAOXADRA2AADRA2BHTR1D
SCHEMBL25970464 0.83 OPRK1 (0.62) OPRK1PAOXADRA2AADRA2BHTR1D
SCHEMBL25969157 0.83 OPRK1 (0.65) OPRK1PAOXADRA2AADRA2BHTR1D
SCHEMBL1718891 0.83 KDM4E (0.67) OPRK1PAOXADRA2AADRA2BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250161307-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE JANSSEN PHARMACEUTICA NV (BE) 2025-05-22 US disclosed
EP-4469454-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE Janssen Pharmaceutica NV (BE) 2024-12-04 EP disclosed
WO-2023141866-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 WO disclosed
WO-2023141866-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250161307-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE SMOX, SRM, SMS OPRK1 2700/4885PAOX 414/4885ADRA2A 1831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.